A recent anonymous formal complaint has been lodged with the Internal Control Body of the Mexican Institute of Social Security (IMSS) calling for an investigation into two contracting procedures at the Hospital de Cardiología, part of the National Medical Center Siglo XXI. The complaint signals potential administrative irregularities, significant financial discrepancies, and the use of an awarding method that is not recognized under Mexican law. These issues raise concerns regarding the transparency and legality of procurement practices within this medical institution.

The allegations stem from specific public documents cited in the official procurement platform ComprasMX, detailing contracting procedures AA-50-GYR-050GYR057-T-146-2025 and AA-50-GYR-050GYR057-T-149-2025. Both contracts were awarded to the supplier INALMEDICA, S.A. de C.V., which enhances the scrutiny of these processes. The complaint expresses a necessity for thorough examination without prejudging any responsibility, highlighting the importance of maintaining accountability in public spending, particularly in the health sector during challenging economic times.

As the IMSS is a pivotal institution in Mexico's healthcare system, these procurement allegations could have significant implications not only for the institution's operational integrity but also for public trust. An investigation might not only clarify the legal standing of these contracts but could also reinforce or undermine the perception of governance in public health entities, thus impacting future procurement processes within similar organizations across the country.